CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitorsXue Lu, Kum Kum Khanna, Michael Friedländer et al.|Journal of Experimental & Clinical Cancer Research|2022Cited by 14
A high-throughput in vivo selection method for luciferase variantsMeiling Sun, Zhuo Tang, Chao Wang et al.|Sensors and Actuators B Chemical|2018Cited by 6
Additional file 3 of CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitorsXue Lu, Kum Kum Khanna, Yaowu He et al.|Open MIND|2023Cited by 0